Salt and water retention, a cardinal feature of nephrotic syndrome, was suggested to be an important factor leading to reduced diurnal blood pressure (BP) variation in renoparenchymal disease. Twenty-four hour BP (SpaceLabs SL 90207), 24-h urine excretion of catecholamines, plasma renin activity and plasma aldosterone concentration were therefore determined in 10 nephrotic patients with normal serum creatinine levels (group A, serum creatinine 1.0 ± 0.2 mg/dl), in 10 nephrotic patients with increased serum creatinine levels (group B, serum creatinine 2.4 ± 0.9 mg/dl) and in 20 controls matched in respect of age and BP. To study the direct influence of fluid volume overload, diurnal BP variation was determined before and after volume depletion by ultrafiltration in 10 patients with end-stage renal failure. Diurnal BP variation was characterised by the difference of mean BP during daytime (10 pm to 8
Introduction
In normotension and in essential hypertension circadian blood pressure (BP) variation is characterised by a diurnal rise and a nocturnal fall in BP. 1, 2 An absence of nocturnal decline in BP has been well documented in patients with renal failure. 3, 4 The mechanism leading to the attenuation of diurnal BP variation is not known. Salt and water retention was suggested to be an important factor leading to reduced circadian BP variation in renal failure. The importance of salt and water retention was also stressed in other forms of secondary hypertension, particularly in conditions with fluid volume expansion like primary aldosteronism, Cushing's disease and hypertensive pregnancy. [5] [6] [7] However, up to now there are no studies on circadian BP variation in patients with excessive fluid volume overload. Sodium and water retention by the kidney is a cardinal feature of the nephrotic syndrome. The increased sodium and water retention in nephrotic syndrome has been related to an inability to excrete am) and night-time (8 am to 10 pm). In group A, the systolic and diastolic day-night difference was not changed when compared with the controls (NS). In contrast, in group B the day-night difference was significantly lower than in the controls (P Ͻ 0.01). Twenty-four hour urine catecholamine excretion and plasma aldosterone were comparable between the study groups. Plasma renin activity, however, was significantly increased in group A (P Ͻ 0.05). Nocturnal BP drop was not related to plasma renin activity in the nephrotic patients. The blunted diurnal blood pressure variation in end-stage renal failure was not influenced by ultrafiltration. The study demonstrates that the blunted diurnal BP variation in kidney disease is unaffected by marked changes in total exchangeable sodium and fluid volume, but is sensitive to changes in glomerular filtration rate. sodium due to intrinsic renal abnormalities and elevated renin-angiotensin-aldosterone levels. [8] [9] [10] [11] Increased total exchangeable sodium, fluid volume overload and a stimulation of renin-angiotensinaldosterone system may influence circadian BP. We therefore hypothesised that circadian BP variation will also be absent in patients with nephrotic syndrome. Circadian BP variation was thus investigated in nephrotic patients with preserved renal function and with renal failure. To study the direct influence of fluid volume overload on diurnal BP variation, the effect of acute volume depletion by ultrafiltration on circadian BP rhythm was determined in patients with end-stage renal failure.
Patients and methods
To investigate circadian BP variation in nephrotic syndrome, 24-h BP was monitored in 20 patients with nephrotic syndrome and in 20 control subjects. The patients were divided into two study groups according to renal function. In group A, nephrotic patients with a normal renal function suggested by a serum creatinine level of Ͻ1.0 mg/dl in female and of Ͻ1.2 mg/dl in male subjects were included. In group B, nephrotic patients with increased serum creatinine levels were included (serum creatinine у1.0 mg/dl in female and у1.2 mg/dl in male patients). The underlying causes of nephrotic syndrome are shown in Table 1 . The patients with nephrotic syndrome were not treated at the time of investigation and were otherwise healthy in routine clinical examination. There were no signs of cardiac dysfunction in the electrocardiogram, X-ray examination of the chest and echocardiogram. BP was measured after a rest of 10 min by three independent readings using a sphygmomanometer. Fourteen nephrotic patients were matched in respect of age and BP with healthy controls. Six nephrotic patients had BP levels of Ͼ140 mm Hg systolic and Ͼ90 mm Hg diastolic (means: systolic BP 152 ± 7 mm Hg, diastolic BP 97 ± 6 mm Hg). These hypertensive nephrotic patients were matched with six essential hypertensive patients, since circadian BP variation is unaffected in essential hypertension. 4 The essential hypertensive patients had otherwise no concomitant disease in routine clinical examination. In these patients serum creatinine and urine sediment, 24-h urine excretion of catecholamines, plasma renin activity and plasma aldosterone concentration were determined and a sonogram of the kidney and arteriography of the renal arteries were performed to exclude secondary forms of arterial hypertension. Twenty-four hour urine excretion of catecholamines, 12 plasma renin activity and plasma aldosterone concentration 13 were also determined in the healthy controls and the patients with nephrotic syndrome. The blood samples were taken from an arm vein early in the morning after the patients remained recumbent for at least 10 h.
The clinical characteristics of the different study groups are shown in Table 1 . Twenty-four hour proteinuria and serum protein levels were not significantly different between the nephrotic groups with normal and with increased serum creatinine levels ( Table 2) .
To investigate the effect of acute volume Table 2 Clinical characteristics of the nephrotic patients with normal (group A) and with increased serum creatinine levels (group B) and of the corresponding control groups
Age (years) 37 ± 14 34 ± 10 44 ± 8 4 1 ± 12 Female/male 3/7 4/6 2/8 3/7 BMI (kg/m 2 ) 26.8 ± 2.0** 22.3 ± 1.2 26.0 ± 1.9** 22.7 ± 2.0 Serum creatinine (mg/ml)
3.5 ± 0.6** 6.7 ± 0.3 4.0 ± 0.4** 6.6 ± 0.4
Means ± standard deviation. BMI, body mass index. Analysis of variance, **P Ͻ 0.01 vs control group.
depletion, 24-h BP variation was also recorded in 10 patients with end-stage renal failure (age 47 ± 18 years) before and after ultrafiltration. Patients with a body weight exceeding the optimal dry weight by about 4 kg were included into study. The body weight decreased from 68.2 ± 3.2 kg before to 64.1 ± 2.7 kg after ultrafiltration. Twenty-four hour BP was recorded before ultrafiltration and 24-h BP registration was repeated 2 to 4 h after ultrafiltration was stopped. The patients were encouraged to restrict fluid intake during a period of 30 h after ultrafiltration. At the end of this period body weight was 64.9 ± 2.9 kg. Systolic and diastolic 24-h BP was recorded using the automatic oscillometric BP recorder SpaceLabs SL 90207 (SpaceLabs, Redmond WA, USA).
14 BP was measured from 8 am to 10 pm in intervals of 15 min and from 10 pm to 8 am in intervals of 30 min. The diurnal variability of BP was characterised by the difference between mean systolic and diastolic BP during daytime (8 am to 10 pm) and night-time (10 pm to 8 am).
Statistical analysis
Values are given as mean ± standard deviation. The clinical parameter and the parameter obtained by 24-h BP monitoring between the nephrotic study groups and control groups were tested for statistical significance by analysis of variance. The Student's t-test for paired samples was used to compare the parameter of 24-h BP monitoring before and after ultrafiltration. Linear regression analysis was performed to assess the relationship between plasma renin activity and diurnal BP variation. The overall test for coincidence of two regressions using the F-test was performed to analyse the hypothesis that the two regressions of the nephrotic group with normal and increased serum creatinine levels are coincident, that is, have the same slope and intercept. A level of P Ͻ 0.05 was considered to be statistically significant.
Results
The body mass index was significantly elevated in the nephrotic group with normal serum creatinine levels as well as in the group with increased serum creatinine levels when compared with the control group. Despite different renal function, however, there was no significant difference of body mass index between both groups with nephrotic syn- Table 3 Twenty-four hour urine excretion of noradrenaline, adrenaline, normetanephrine and metanephrine, plasma renin activity and plasma aldosterone concentration in the nephrotic patients with normal (group A) and with increased serum creatinine levels (group B) and in the corresponding control groups
Noradrenaline
4.4 ± 3.4* 1.6 ± 0.9 3.9 ± 2.1 2.2 ± 0.9 (0.2-3.0) Plasma aldosterone (pg/ml) 76 ± 48 29 ± 22 61 ± 37 37 ± 24 (20-120)
Means ± standard deviation. Analysis of variance, *P Ͻ 0,05 vs control group. drome ( Table 2 ). Twenty-four hour urine excretion of adrenaline, noradrenaline, metanephrine and normetanephrine did not differ between the study groups ( Table 3 ). Plasma renin activity was significantly increased in the nephrotic group with normal serum creatinine levels when compared with the control group. Plasma renin activity was also higher in the nephrotic group with increased serum creatinine levels when compared to the control group, but the difference failed to reach statistical significance (Table 3 ). Plasma aldosterone concentration was insignificantly increased in the nephrotic group with normal renal function and with renal failure. However, there were no significant differences of plasma renin activity and plasma aldosterone concentrations between the nephrotic group with normal and increased serum creatinine levels, respectively.
In the nephrotic patients with normal serum creatinine levels, the day-night difference of the systolic and diastolic BP was not significantly different when compared with the healthy controls. This finding contrasts with a blunted diurnal BP variation in the nephrotic group with increased serum creatinine levels. The systolic and diastolic daynight difference was significantly decreased in the nephrotic group with impaired renal function when compared with the control group (Table 4, Figure  1 , P Ͻ 0.05). The day-night BP difference was also significantly reduced in the nephrotic patients with increased serum creatinine levels in comparison to the nephrotic patients with normal serum creatinine Table 4 Mean systolic and diastolic 24-h BP and heart rate, day-night difference of systolic and diastolic BP and of heart rate in the nephrotic patients with normal (group A) and with increased serum creatinine levels (group B) and in the corresponding control groups
24-h BP systolic (mm Hg) 121 ± 9 130 ± 9 144 ± 9## 146 ± 9## diastolic (mm Hg) 78 ± 9 7 9 ± 6 8 9 ± 8## 91 ± 9# 24-hour HF (/min) 74 ± 9 7 1 ± 5 7 9 ± 8 7 4 ± 6
Day-night difference systolic BP (mm Hg) 15 ± 5 1 5 ± 6 7 ± 4**, # 18 ± 7 diastolic BP (mm Hg) 11 ± 5 1 0 ± 4 5 ± 3**, # 12 ± 6
Day-night difference (HF (/min) 13 ± 4 1 5 ± 6 8 ± 5 1 2 ± 4
Means ± standard deviation. Group A: nephrotic patients with normal serum creatinine levels; Group B: nephrotic patients with increased serum creatinine levels. BP, blood pressure: HF, heart rate; analysis of variance, *P Ͻ 0.05, **P Ͻ 0.01 vs control group, #P Ͻ 0.05, ##P Ͻ 0.01 vs group A.
Figure 1
Day-night difference of systolic and diastolic BP in the nephrotic patients with normal (n = 10) and increased serum creatinine levels (n = 10) and in the corresponding control groups. CR, serum creatinine levels. levels (P Ͻ 0.05). The day-night difference of BP was not related to plasma renin activity. This was true for the group with normal (r = 0.17, NS, n = 10) and increased serum creatinine levels (r = 0.24, NS; n = 10) (Figure 2 ) and if the data of both nephrotic groups were pooled together (r = 0.20, NS; n = 20).
Figure 2
Relationship between the day-night difference of mean arterial pressure (mm Hg) and plasma renin activity (ng/ml*h) in the nephrotic patients with normal (r = 0.17, P = 0.63; n = 10) and increased serum creatinine levels (r = 0.24, P = 0.51; n = 10. CR, serum creatinine levels.
The overall test of coincidence of the two regression lines using the F-test showed that the regressions between the nephrotic group with normal and increased serum creatinine level were not significantly different (F = 3.04, NS). Mean systolic and diastolic 24-h BP was significantly higher in the nephrotic group with normal serum creatinine levels than in the nephrotic patients with increased serum creatinine levels. However, the level of BP was not related to the systolic and diastolic day-night difference which was reduced in the normotensive as well in the hypertensive nephrotic patients with renal failure. In the normotensive patients with increased serum creatinine levels, the day-night difference was 8 ± 3 mm Hg systolic and 4 ± 2 mm Hg diastolic (n = 5), in the hypertensive patients with increased serum creatinine levels they were 6 ± 4 mm Hg systolic and 5 ± 3 mm Hg diastolic (n = 5).
Mean systolic and diastolic 24-h BP decreased slightly after ultrafiltration, but the difference in BP before and after ultrafiltration was not statistically significant. Before ultrafiltration mean 24-h BP was 144 ± 20 mm Hg systolic and 81 ± 12 mm Hg diastolic, after ultrafiltration systolic BP was 136 ± 20 mm Hg and diastolic BP 78 ± 6 mm Hg (NS). The diurnal variation of systolic and diastolic BP was absent in the patients group with end-stage renal failure. The day-night difference of BP before ultrafiltration was 2.3 ± 11 mm Hg systolic and −0.5 ± 4 mm Hg diastolic. Although volume depletion by ultrafiltration was associated with a marked reduction of body weight, the nocturnal decline of the systolic and the diastolic BP was not influenced by ultrafiltration. After ultrafiltration the day-night BP was 3 ± 7 mm Hg systolic and 0.7 ± 5 mm Hg diastolic (Figure 3 ).
Discussion
The results show that circadian BP variation is not altered in nephrotic syndrome with normal renal function. The patients were characterised by pro- nounced peripheral oedema and, in most cases, by an activated renin-angiotensin system. Therefore the findings suggest that sodium and water retention and alterations in the renin-angiotensin axis do not affect circadian BP variability in these patients. On the other hand, a decreased glomerular filtration rate in patients with nephrotic syndrome was associated with a markedly diminished circadian BP variability. Thus a decreased glomerular filtration appears to influence circadian BP variation independently from changes in intravascular and extracellular volume.
By what mechanism may glomerular filtration influence BP variation? The plasma levels of several hormones show a pattern compatible with the physiological pattern of BP. [15] [16] [17] Nevertheless, when sympathoadrenergic influences are eliminated, the physiological circadian variation of peripheral vascular resistance is abolished. 18 Apparently, the sympathoadrenergic system plays a major role in producing the physiological circadian BP variation. [18] [19] [20] As a second important finding, profound alterations in sympathetic tone have been described in renal failure. [21] [22] [23] Moreover, the increased sympathetic discharges in renal failure may not be caused by accumulation of uremic toxins, but depend on afferent signals from the failing kidney. This was suggested by the finding that sympathetic activity was increased in uremic patients, who had not undergone nephrectomy, but was normal in bilaterally nephrectomized patients. 21 Noteworthy, increased sympathetic discharge was constant throughout the interval between dialysis treatment despite a large increase in total body water suggesting that sympathetic activity is unaffected by changes in extracellular volume. Both aforementioned findings, the dominant influence of the sympathetic nervous system on the 24-h BP variation and the markedly altered sympathetic nerve activity in renal failure, can readily explain our results that circadian BP variation depends on renal function in nephrotic patients.
The findings in the present study may help to further elucidate the changes of circadian BP variation in renal failure. In earlier studies, decreased circadian BP variation in renal failure was observed, but there is still considerable uncertainty as to the underlying mechanism. 3, 4, 24, 25 The concomitant salt and water retention was suggested as the most likely explanation. Since in our study the effects of changes in extracellular volume and in renal excretory function were separated, the data suggest that sodium and water retention is not the major factor responsible for the blunted circadian BP variation in renal failure. It may be argued that in nephrotic syndrome mostly intravascular volume is decreased. However, in our nephrotic patients, we found both increased and decreased plasma renin activity, suggesting that both decreased and increased intravascular volumes may occur. There was no correlation between plasma renin activities and day-night BP differences. Therefore it seems unlikely that BP variation with increased and decreased intravascular volume should differ significantly.
In conclusion, the study demonstrates that the physiological 24-h BP variation is unaffected by marked changes in extracellular and intravascular volume, but is very sensitive to changes in glomerular filtration rate. Even a modest impaired renal function is associated with a decreased circadian BP variation. We failed to observe an influence of the renin-angiotensin system.
